51 results on '"Laus, G."'
Search Results
2. P76.72 A PET and MRI Study Exploring Osimertinib Brain Exposure and Efficacy in EGFRm NSCLC CNS Metastases
3. Osimertinib versus platinum–pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis
4. Frequenz von EGFR (epidermaler Wachstumsfaktorrezeptor)-Mutationen im Stadium IB-IIIA NSCLC nach kompletter Tumorresektion
5. Overall survival (OS) from the AURA3 phase III study: Osimertinib vs platinum-pemetrexed (plt-pem) in patients (pts) with EGFR T790M advanced non-small cell lung cancer (NSCLC) and progression on a prior EGFR-tyrosine kinase inhibitor (TKI)
6. Frequency of epidermal growth factor receptor (EGFR) mutations in stage IB–IIIA EGFR mutation positive non-small cell lung cancer (NSCLC) after complete tumour resection
7. P2.14-33 An Open-Label PET-MRI Study to Determine Brain Exposure of Osimertinib in Patients with EGFR Mutant NSCLC and CNS Metastases
8. Synthesis of Potent and Enzymatically Stable 4–18F-Benzoyl-NT(8–13) Analogs for Tumour Diagnosis Using PET
9. Conformationally restricted new somatostatin analogs
10. Analysis of resistance mechanisms to osimertinib in patients with EGFR T790M advanced NSCLC from the AURA3 study
11. Overall survival (OS) in patients (pts) with EGFR T790M-positive advanced non-small cell lung cancer (NSCLC) treated with osimertinib: Results from two phase II studies
12. Phase-out-compliant fluorosurfactants: unique methimazolium derivatives including room temperature ionic liquids
13. SIMO and MIMO PHIL Methods for Distributed Generation in LV Networks
14. Synthesis of Substituted Benzoxazolinones by the Curtius Rearrangement: Crystal Structures of Intermediates and By-Products
15. Inhibition of NF-κB activation by the histone deacetylase inhibitor 4-Me2N-BAVAH induces an early G1cell cycle arrest in primary hepatocytes
16. Inhibition of NF-?B activation by the histone deacetylase inhibitor 4-Me2N-BAVAH induces an early G1cell cycle arrest in primary hepatocytes
17. A Metabolic Screening Study of Trichostatin A (TSA) and TSA-Like Histone Deacetylase Inhibitors in Rat and Human Primary Hepatocyte Cultures
18. 399 POSTER Synergistic antitumor activity of the combination of the multi-targeted tyrosine kinase inhibitor sorafenib and of EGFR inhibitors in human colon and lung cancer cell lines
19. 397 POSTER Potentiation of the antitumor activity of bortezomib, a proteasome inhibitor, by the combination with EGFR inhibitors in human cancer cell lines
20. Role of metalloproteinase-7 in oxaliplatin acquired resistance in colorectal cancer cell lines
21. Crystal structure of (E)-2-ruthenocenylethenylcobaltocenium hexafluorophosphate, [(C5H5)Ru(C12H10)Co(C5H5)] [PF6]
22. Crystal structure of (E)-2-ruthenocenylethenylcobaltocenium hexafluorophosphate, [(C5H5)Ru(C12H10)Co(C5H5)][PF6]
23. Lattice Architecture and Hydrogen-Bonding Networks of N-Aminoazolium and N,N‘-Diaminoazolium Chlorides
24. Electrochemical bromination of cholest-5-enes
25. Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors
26. Crystal structure of sodium 4-azido-1,2,3-triazolide monohydrate, Na(N3C2HN3) · H2O
27. Crystal structure of bis( 1 -butyl-3-methylimidazolium) hexachlorotitanate( IV) bis(dichloromethane) solvate, (C8H15N2)2[TiCl6] · 2CH2Cl2
28. Crystal structure of iodoferrocene, Fe(C5H4I)(C5H5)
29. Crystal structure of 17-(cyclopropylmethyl)-6,7-didehydro-4,5a-epoxy-3- hydroxy-14β-(3-phenylpropyloxy)indolo[2,3:6,7]morphinan hydroiodide, (C35H37N2O3)I
30. Ionic Liquids as Advantageous Solvents for Headspace Gas Chromatography of Compounds with Low Vapor Pressure
31. Poly(ADP-ribose)polymerase (PARP-1) expression in malignant melanomas from photo exposed areas of the head and neck region
32. Crystal structure of bis(ferroceno[2,3]inden-1-yl)dimethylsilane, Si(CH3)2[Fe(C5H5)(C12H8)]2
33. Epidermal growth factor receptor (EGFR) expression in cutaneous melanoma: A possible role as prognostic marker
34. Crystal structure of 5,6-didehydro-14-hydroxy-3-methoxy-17-methy1-4- (trifluoromethylsulfonyIoxy)morphinan-6-carbonitrile, C20H21F3N2O5S
35. Major Phase I Biotransformation Pathways of Trichostatin A in Rat Hepatocytes and in Rat and Human Liver Microsomes
36. ChemInform Abstract: 1‐Hydroxyimidazole Derivatives. Part 4. Quaternary Salts Derived from 1‐Hydroxy‐1H‐imidazoles.
37. ChemInform Abstract: 1‐Amino‐1H‐1,2,4‐triazole Derivatives.
38. ChemInform Abstract: 1‐Hydroxyimidazole Derivatives. Part 3. Synthesis of 1‐Alkyloxy‐, 1‐Arylalkyloxy‐, and 1‐Phenoxy‐1H‐imidazoles.
39. ChemInform Abstract: Cleromyrine I, a New Cyclohexapeptide from Clerodendrum myricoides
40. Benzo- and Indoloquinolizidine Derivatives XIX. The Synthesis and Pharmacologocal Activity of Some Quinolizidine Derivatives, Analogues of Butaclamol
41. Cleromyrine I, a new cyclohexapeptide from clerodendrum myricoides
42. Covalent binding of a photoreactive derivative of estrone to rat α-fetoprotein (AFP)
43. Monitoring of Deprotection Reactions of Cyclic Somatostatin Analogues by Fast Atom Bombardment Mass Spectrometry
44. ChemInform Abstract: BENZO- AND INDOLOQUINOLIZINE DERIVATIVES. 13. CONFORMATION OF THE PERHYDROBENZO(C)QUINOLIZINES
45. ChemInform Abstract: BENZO- AND INDOLOQUINOLIZIDINE DERIVATIVES. XIX. THE SYNTHESIS AND PHARMACOLOGICAL ACTIVITY OF SOME QUINOLIZIDINE DERIVATIVES, ANALOGS OF BUTACLAMOL
46. Benzo- and indoloquinolizines. XII—carbon-13 n.m.r. study of the conformation of the 1,2,3,4,4a,6,7,8,9,13b-decahydro-9aH-pyrido[1,2-f]phenanthridine isomers
47. Determination of the chiral purity of dipeptide isosteres containing a reduced peptide bond by gas chromatographic analysis
48. Benzo- and indoloquinolizine derivatives—XVII
49. ChemInform Abstract: Synthesis of 1‐Amino‐1H‐1,2,4‐triazoles.
50. Benzo‐ and indolo‐quinolizine derivatives XI—The configurational and conformational study of 1,2,3,4,4a,6,7,8,9,13b‐decahydro‐9aH‐pyrido[1,2‐f]phenanthridine isomers by 270 MHz 1H n.m.r.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.